Gut bacteria linked to cardiovascular, other health conditionsAugust 31, 2020DiabetesEndocrinologyCardiology
DAPA-CKD: SGLT2 inhibitor benefit extends to chronic kidney disease without diabetesAugust 31, 2020DiabetesCardiologyNephrologyEndocrinology
EMPEROR-Reduced: Empagliflozin’s HFrEF benefit solidifies class effectsAugust 30, 2020DiabetesCardiologyEndocrinology
Diabetes plus weight loss equals increased risk of pancreatic cancerAugust 19, 2020GastroenterologyDiabetes
Does metformin reduce risk for death in COVID-19?August 14, 2020COVID-19 UpdatesDiabetesEndocrinology
Unexpected rosuvastatin-canagliflozin adverse effect reportedAugust 4, 2020DiabetesCardiologyEndocrinology
COVID-19 taking financial toll on people in U.S. with diabetesAugust 3, 2020DiabetesCOVID-19 UpdatesEndocrinology
Real-world data show SGLT2 inhibitors for diabetes triple DKA riskJuly 29, 2020DiabetesEndocrinologyNephrologyCardiology
Cleaner data confirm severe COVID-19 link to diabetes, hypertensionJuly 27, 2020DiabetesCardiologyEndocrinologyCOVID-19 Updates
